It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 1993.
1993 | Chennai, Tamil Nadu, India | ActiveMedicorp Pharmaceuticals India Private Limited, a active private limited company, was established on 07 May 1993 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231TN1993PTC025019. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹5.38 Cr.
It upholds a compliant status. Its leadership includes Raghunath Dash (Additional Director), Srivatsan (Director), Vijayaraghavan Seshadri (Additional Director). Past directors included Seshadri Lakshmanan, Mukherji Subroto Lal, Subramnaiaiyer Venkatakrishnan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B22 Mogappair West Chennai 37, Chennai, Tamil Nadu, 600037.
U24231TN1993PTC025019
025019
07 May 1993
₹12.00 Cr
₹5.38 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Medicorp Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghunath Dash | Additional Director | 02 Mar 2020 | Current |
| Srivatsan | Director | 01 Aug 2020 | Current |
| Vijayaraghavan Seshadri | Additional Director | 29 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 May 2019 | Past |
| Pramod Abcsdd | Director | 13 Oct 2019 | Past |
| Pramod Abcsdd | Director | 13 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medicorp Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 351454.54% decrease in profit. The company's net worth observed a substantial decline by a decrease of 100.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Medicorp Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medicorp Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medicorp Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicorp Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medicorp Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Medicorp Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Srivatsan was appointed as a Director was appointed as a Director on 01 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Progress on Raghunath Dash was appointed as a Additional Director was appointed as a Additional Director on 02 Mar 2020 & has been associated with this company since 5 years 8 months . was documented.
The activity Vijayaraghavan Seshadri was appointed as a Additional Director was appointed as a Additional Director on 29 May 2019 & has been associated with this company since 6 years 6 months . was completed.
Medicorp Pharmaceuticals India Private Limited was registered on 07 May 1993 with Roc Chennai & aged 32 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Medicorp Pharmaceuticals India Private Limited is U24231TN1993PTC025019.
Medicorp Pharmaceuticals India Private Limited is headquartered at B22 Mogappair West Chennai 37, Chennai, Tamil Nadu, 600037.
Medicorp Pharmaceuticals India Private Limited was incorporated on 07 May 1993.
The current directors of Medicorp Pharmaceuticals India Private Limited are
The primary industry of Medicorp Pharmaceuticals India Private Limited is Pharma.
Medicorp Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Medicorp Pharmaceuticals India Private Limited is ₹12.00 Cr, and the paid-up capital is ₹5.38 Cr.
The compliance status of Medicorp Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX